دورية أكاديمية
A randomized controlled trial of shared decision-making treatment planning process to enhance shared decision-making in patients with MBC.
العنوان: | A randomized controlled trial of shared decision-making treatment planning process to enhance shared decision-making in patients with MBC. |
---|---|
المؤلفون: | Rocque GB; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA. grocque@uabmc.edu.; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA. grocque@uabmc.edu.; Division of Gerontology/Geriatrics/Palliative Care, Department of Medicine, University of Alabama at Birmingham, South, AL, 35294, USA. grocque@uabmc.edu., Eltoum N; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Caston NE; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Williams CP; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.; Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Oliver MM; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Moradi L; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Ingram S; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Azuero A; School of Nursing, University of Alabama at Birmingham, Birmingham, AL, USA., Pisu M; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.; Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Bhatia S; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA. |
المصدر: | Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Aug; Vol. 206 (3), pp. 483-493. Date of Electronic Publication: 2024 Jun 10. |
نوع المنشور: | Journal Article; Randomized Controlled Trial |
اللغة: | English |
بيانات الدورية: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
أسماء مطبوعة: | Publication: Dordrecht : Kluwer Academic Original Publication: The Hague ; Boston : M. Nijhoff, c1981- |
مواضيع طبية MeSH: | Breast Neoplasms*/psychology , Breast Neoplasms*/therapy , Decision Making, Shared* , Patient Participation*, Humans ; Female ; Middle Aged ; Aged ; Physician-Patient Relations ; Patient Preference ; Adult ; Patient Care Planning |
مستخلص: | Purpose: Opportunities exist for patients with metastatic breast cancer (MBC) to engage in shared decision-making (SDM). Presenting patient-reported data, including patient treatment preferences, to oncologists before or during a treatment plan decision may improve patient engagement in treatment decisions. Methods: This randomized controlled trial evaluated the standard-of-care treatment planning process vs. a novel treatment planning process focused on SDM, which included oncologist review of patient-reported treatment preferences, prior to or during treatment decisions among women with MBC. The primary outcome was patient perception of shared decision-making. Secondary outcomes included patient activation, treatment satisfaction, physician perception of treatment decision-making, and use of treatment plans. Results: Among the 109 evaluable patients from December 2018 to June 2022, 28% were Black and 12% lived in a highly disadvantaged neighborhood. Although not reaching statistical significance, patients in the intervention arm perceived SDM more often than patients in the control arm (63% vs. 59%; Cramer's V = 0.05; OR 1.19; 95% CI 0.55-2.57). Among patients in the intervention arm, 31% were at the highest level of patient activation compared to 19% of those in the control arm (V = 0.18). In 82% of decisions, the oncologist agreed that the patient-reported data helped them engage in SDM. In 45% of decision, they reported changing management due to patient-reported data. Conclusions: Oncologist engagement in the treatment planning process, with oncologist review of patient-reported data, is a promising approach to improve patient participation in treatment decisions which should be tested in larger studies. Trial Registration: NCT03806738. (© 2024. The Author(s).) |
References: | Health Serv Res. 2004 Aug;39(4 Pt 1):1005-26. (PMID: 15230939) Breast. 2021 Oct;59:232-238. (PMID: 34304064) J Pain Symptom Manage. 2012 Apr;43(4):663-78. (PMID: 22464352) Health Qual Life Outcomes. 2004 Feb 26;2:12. (PMID: 14987333) Cancer. 2013 Jan 1;119(1):158-63. (PMID: 23197186) BMJ. 2010 Mar 23;340:c869. (PMID: 20332511) JAMA Oncol. 2020 Feb 1;6(2):196-204. (PMID: 31697365) Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2203915119. (PMID: 35914161) J Geriatr Oncol. 2020 Mar;11(2):203-211. (PMID: 31451439) Clin Breast Cancer. 2021 Feb;21(1):37-46. (PMID: 32741667) Oncologist. 2011;16(12):1800-5. (PMID: 22128118) Can J Nurs Res. 1997 Fall;29(3):21-43. (PMID: 9505581) J Palliat Care. 2019 Jan;34(1):29-31. (PMID: 30382006) Qual Life Res. 2010 Apr;19(3):371-9. (PMID: 20146009) J Clin Oncol. 2018 Mar 1;36(7):659-666. (PMID: 29364772) J Geriatr Oncol. 2020 Nov;11(8):1324-1328. (PMID: 32732011) BMC Public Health. 2013 Dec 12;13:1169. (PMID: 24330527) Cancer. 2020 Aug 1;126(15):3534-3541. (PMID: 32426870) JAMA. 2014 Jul 16;312(3):240-8. (PMID: 25027139) Ann Oncol. 2010 Jun;21(6):1145-1151. (PMID: 19940010) Oncologist. 2019 Oct;24(10):1313-1321. (PMID: 30872466) Patient Educ Couns. 2017 Jul;100(7):1276-1279. (PMID: 28330715) JCO Oncol Pract. 2022 Nov;18(11):737-741. (PMID: 36252157) Health Qual Life Outcomes. 2022 May 21;20(1):82. (PMID: 35597948) Cancer. 2013 Jan 1;119(1):164-72. (PMID: 23197335) J Clin Oncol. 2016 Feb 20;34(6):557-65. (PMID: 26644527) J Natl Compr Canc Netw. 2022 Jun;20(6):691-722. (PMID: 35714673) JAMA Oncol. 2021 Nov 01;7(11):e214158. (PMID: 34591080) J Oncol Pract. 2017 Aug;13(8):512-514. (PMID: 28613969) Am J Manag Care. 2010 Sep;16(9):688-96. (PMID: 20873956) Cancer. 2021 Feb 1;127(3):449-457. (PMID: 33108023) J Natl Cancer Inst. 2023 Nov 8;115(11):1271-1277. (PMID: 37421403) J Clin Oncol. 2006 Feb 20;24(6):904-9. (PMID: 16484700) J Clin Oncol. 2004 Aug 1;22(15):3091-8. (PMID: 15284259) JAMA. 2004 Jul 28;292(4):435-41. (PMID: 15280341) Target Oncol. 2016 Jun;11(3):277-92. (PMID: 26677846) Health Serv Res. 2005 Dec;40(6 Pt 1):1918-30. (PMID: 16336556) JAMA. 2018 Jun 5;319(21):2223-2224. (PMID: 29872845) J Clin Oncol. 2016 Nov 20;34(33):4047-4048. (PMID: 27551131) J Racial Ethn Health Disparities. 2018 Feb;5(1):117-140. (PMID: 28275996) J Clin Oncol. 2011 Mar 10;29(8):994-1000. (PMID: 21282546) JCO Oncol Pract. 2022 May;18(5):e731-e739. (PMID: 34995081) Am J Public Health. 2003 Jul;93(7):1137-43. (PMID: 12835199) J Oncol Pract. 2012 Nov;8(6):e142-8. (PMID: 23598849) |
معلومات مُعتمدة: | MRSG- 17-051-01 -PCSM American Cancer Society |
فهرسة مساهمة: | Keywords: Metastatic breast cancer; Patient-reported data; Shared decision-making; Treatment planning |
سلسلة جزيئية: | ClinicalTrials.gov NCT03806738 |
تواريخ الأحداث: | Date Created: 20240610 Date Completed: 20240626 Latest Revision: 20240629 |
رمز التحديث: | 20240629 |
مُعرف محوري في PubMed: | PMC11208240 |
DOI: | 10.1007/s10549-024-07304-y |
PMID: | 38856885 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1573-7217 |
---|---|
DOI: | 10.1007/s10549-024-07304-y |